EZH2 and systemic lupus erythematosus: Therefore, we speculate that EZH2 may promote B cell proliferation and inhibit B cell apoptosis by regulating cyclin-dependent kinase inhibitors in SLE, thereby abnormally proliferating plasma cells, leading to the production of autoantibodies.